Cargando…

Prevalence of COVID-19 infection in patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis

Detalles Bibliográficos
Autores principales:	Ghajarzadeh, Mahsa, Moghadasi, Abdorreza Naser, Mohammadi, Aida, Sahraian, Mohammad Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498318/ http://dx.doi.org/10.1016/j.jns.2021.118199

Ejemplares similares

Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Eculizumab in the treatment of neuromyelitis optica spectrum disorder
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

Disability and Therapeutic Response in Paediatric Neuromyelitis Optica Spectrum Disorder: A Case Series from Iran
por: BAGHBANIAN, Seyed Mohammad, et al.
Publicado: (2019)

Whole grains and legumes consumption in association with neuromyelitis optica spectrum disorder odds
por: Rezaeimanesh, Nasim, et al.
Publicado: (2021)

Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder
por: Eskandarieh, Sharareh, et al.
Publicado: (2019)

Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases
por: Seyed Ahadi, Maral, et al.
Publicado: (2020)

The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder
por: Maghbooli, Zhila, et al.
Publicado: (2021)

The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder
por: Rezaeimanesh, Nasim, et al.
Publicado: (2022)

Adding erythropoietin to intravenous methylprednisolone in acute treatment of attacks of neuromyelitis optica spectrum disorders: A randomized controlled trial
por: Shafaei, Maryam, et al.
Publicado: (2022)

Increased Intracranial Pressure on a Patient with Neuromyelitis Optica Spectrum Disorder
por: Forouzannia, Seyed Mohammad, et al.
Publicado: (2021)

Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report
por: Sahraian, Mohammad Ali, et al.
Publicado: (2015)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD
por: Shi, Mingchao, et al.
Publicado: (2022)

The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2023)

Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
por: Nasirzadeh, Amirreza, et al.
Publicado: (2023)

Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
por: Paybast, Sepideh, et al.
Publicado: (2022)

Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD)
por: Akiba, Ryutaro, et al.
Publicado: (2016)

General anaesthesia for caesarean section in a patient with neuromyelitis optica spectrum disorder (NMOSD)
por: Dusitkasem, Sasima, et al.
Publicado: (2019)

Psychometric assessment of the Persian version of the patient determined disease steps scale in patients with multiple sclerosis and neuromyelitis optica spectrum disorder
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
por: Motahharynia, Ali, et al.
Publicado: (2022)

Sjögren’s syndrome and Neuromyelitis Optica spectrum disorders (NMOSD) – a case report and review of literature
por: Jayarangaiah, Apoorva, et al.
Publicado: (2014)

Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study
por: Tian, De-Cai, et al.
Publicado: (2020)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Barzegar, Mahdi, et al.
Publicado: (2022)

Psychometric properties of the Persian version of emotions and attitudes towards MRI” (MRI-EMA)
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2023)

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD)
por: Bigaut, Kévin, et al.
Publicado: (2019)

Corrigendum to ‘Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study’
por: Tian, De-Cai, et al.
Publicado: (2021)

Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review
por: Mirmosayyeb, O., et al.
Publicado: (2023)

Two Cases of Very-Late-Onset Neuromyelitis Optica Spectrum Disorder (NMOSD) in Patients over the Age of 80
por: Fujiwara, Shunya, et al.
Publicado: (2020)

Clinical and prognostic aspects of patients with the Neuromyelitis Optica Spectrum Disorder (NMOSD) from a cohort in Northeast Brazil
por: Fukuda, Thiago Gonçalves, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

A case of neuromyelitis optica spectrum disorder (NMOSD) and acute myositis following SARS-CoV-2 infection
por: Barone, Stefania, et al.
Publicado: (2021)

Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset
por: Sadeghi-Bahmani, Dena, et al.
Publicado: (2022)

Screening neuromyelitis optica patients for COVID-19 infection
por: Mirmosayyeb, Omid, et al.
Publicado: (2020)

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
por: Jarius, Sven, et al.
Publicado: (2023)

Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s5s6245oc4i8eun6absl3q8mdv